Meglitinides (Nateglinide & Repaglinide): Diabetes Pharmacology Review

Meglitinides (Nateglinide & Repaglinide) can feel like the “forgotten” oral diabetes drugs—but they show up on exams, in real-world medication histories, and in questions about postprandial glucose control and hypoglycemia and weight gain risk. In this lecture from This is Why, Dr. Busti will explain the meglitinides in a clear, clinically relevant way so you can recognize them quickly and use the concepts confidently in the context of Type 2 diabetes (T2DM).You’ll learn how to:- Meglitinides overview: where they fit in type 2 diabetes (T2DM) therapy- Drug names you must know: repaglinide and nateglinide- Mechanism of action: how these insulin secretagogues stimulate insulin release (the KATP channel connection)- Onset/duration & dosing concept: why they’re considered short-acting / prandial glucose agents- Therapeutic application: targeting postprandial hyperglycemia and when they may (or may not) be chosen- Adverse effects & safety: hypoglycemia, weight considerations, and key patient counseling pointsThe goal = make medical education easy and clinically relevant.Access bonus materials and downloads from this episode at: https://www.thisiswhy.health/topics/meglitinides-repaglinide-nateglinide-diabetes-pharmacology-reviewGet more with a free membership at https://www.thisiswhy.health/- Access free downloads from our videos - Access deep dive content from Dr. Busti- Organize content via playlists & collections- Join live Q&A- Receive member newsletters- Coupons & discounts for exam prep resourcesIf this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.Don’t forget to turn on notifications so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!#meglitinides #repaglinide #nateglinide #type2diabetes #bustiDisclaimer:This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.